Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antitumor Activities of Interleukin-12 in Melanoma
Wei Gao, Jun Pan, Jianping Pan
Cancers (2022) Vol. 14, Iss. 22, pp. 5592-5592
Open Access | Times Cited: 17

Showing 17 citing articles:

Phase I trial of phIL12 plasmid intratumoral gene electrotransfer in patients with basal cell carcinoma in head and neck region
Primož Strojan, Tanja Jesenko, Maša Omerzel, et al.
European Journal of Surgical Oncology (2025) Vol. 51, Iss. 5, pp. 109574-109574
Open Access | Times Cited: 4
Cancer immunotherapy focusing on the role of interleukins: A comprehensive and updated study
Mahmoud Samadi, Amin Kamrani, Hadi Nasiri, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154732-154732
Closed Access | Times Cited: 13
Non-clinical evaluation of pmIL12 gene therapy for approval of the phase I clinical study
Boštjan Markelc, Tanja Jesenko, Simona Kranjc, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Unraveling the role of miR-767 in tumor progression: Mechanisms and clinical implications
Zheng Fu, Charlotte Jin, Sihan Yu, et al.
Gene (2025) Vol. 949, pp. 149366-149366
Closed Access
Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review
Simran Kalsi, Amanda L Galenkamp, Rohit Singh, et al.
Current Oncology Reports (2024)
Open Access | Times Cited: 3
Development and validation of an immune signature-based risk model for prognostic assessment in melanoma
Rui Tao, Jingjing Ruan, Xuejie Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Nanoscale, antigen encounter-dependent, IL-12 delivery by CAR T cells plus PD-L1 blockade for cancer treatment
Zhifen Yang, Violena Pietrobon, Maggie Bobbin, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8
A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers
Richard T. Kenney, John K. Cini, Susan Dexter, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage
Michael Agrez, Mark S. Rybchyn, Warusavithana Gunawardena Manori De Silva, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Changes in Serum IL-12 Levels following the Administration of H1-Antihistamines in Patients with Chronic Spontaneous Urticaria
Corina Ene, Milena Tocut, Mircea Tampa, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 295-295
Open Access | Times Cited: 1
Iturin A and Gramicidin A inhibit proliferation, trigger apoptosis, and regulate inflammation in breast cancer cells
Pınar Altın Çelik, Ahmet Eken, Muazzez Derya-Andeden, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106121-106121
Closed Access
Dihydroxyphenylalanine-conjugated high molecular weight polyethylenimine for targeted delivery of Plasmid
Zahra Taheri, Maryam Kazemi, Bahman Khalvati, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Preparation of a Plasma‐Induced Dendritic Cell Vaccine and its Anti‐Tumor Immunity in a Murine Model of Melanoma
Xiangni Wang, J. Liu, Xiying Wang, et al.
Advanced Therapeutics (2024)
Closed Access
Topical and Intralesional Treatments for Skin Metastases and Locoregionally Advanced Melanoma
María Criado‐Otero, María Navedo-de las Heras, E. Samaniego-González
Cancers (2024) Vol. 17, Iss. 1, pp. 67-67
Open Access
Investigating Nano-Sized Tumor-Derived Extracellular Vesicles in Enhancing Anti-PD-1 Immunotherapy
Hesam Abouali, Michelle Przedborski, Mohammad Kohandel, et al.
Nanoscale (2024)
Closed Access
SON-1010: an albumin-binding IL-12 fusion protein that improves cytokine half-life, targets tumors, and enhances therapeutic efficacy
John K. Cini, Richard T. Kenney, Susan Dexter, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells for Oncotherapy
Hao Yu, Xiaonan Yang, Shuang Chen, et al.
Biochemistry (2023)
Open Access
Page 1

Scroll to top